Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry J Henk

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal of Medical Economics|December 16, 2011
Assessment of zoledronic acid treatment patterns and clinical outcomes in patients with bone metastases from genitourinary cancersHenry J Henk, Satyin Kaura
Journal of Medical Economics|October 25, 2011
Retrospective database analysis of the effect of zoledronic acid on skeletal-related events and mortality in women with breast cancer and bone metastasis in a managed care planHenry J Henk, Satyin Kaura
BMC Musculoskeletal Disorders|September 21, 2011
Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort studySarika Ogale, Elena Hitraya, Henry J Henk
Journal of Medical Economics|December 20, 2011
Retrospective evaluation of the clinical benefit of long-term continuous use of zoledronic acid in patients with lung cancer and bone metastasesHenry J Henk, Satyin Kaura, April Teitelbaum
Ophthalmology|January 4, 2003
Atopy: a patient-specific risk factor for diffuse lamellar keratitisStephen M Boorstein, Henry J Henk, Victor M Elner
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 14, 2011
Some cautions on the use of instrumental variables estimators in outcomes research: how bias in instrumental variables estimators is affected by instrument strength, instrument contamination, and sample sizeWilliam H Crown, Henry J Henk, David J Vanness
Mayo Clinic Proceedings|August 20, 2019
Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes: Population-Based Modeling Study, 2011-2014Grace K Mahoney, Henry J Henk, Rozalina G McCoy
Advances in Therapy|November 21, 2015
A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with HyperlipidemiaHenry J Henk, Carly J Paoli, Shravanthi R Gandra
Clinical Therapeutics|December 4, 2014
Real-world analysis of tyrosine kinase inhibitor treatment patterns among patients with chronic myeloid leukemia in the United StatesHenry J Henk, Mabel Woloj, Mark Shapiro, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Novel Type 2 Diabetes Medication Access and Effect of Patient Cost SharingHenry J Henk, Janice M S Lopez, Brahim K Bookhart
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Medical Economics|December 16, 2011
Assessment of zoledronic acid treatment patterns and clinical outcomes in patients with bone metastases from genitourinary cancersHenry J Henk, Satyin Kaura
Journal of Medical Economics|October 25, 2011
Retrospective database analysis of the effect of zoledronic acid on skeletal-related events and mortality in women with breast cancer and bone metastasis in a managed care planHenry J Henk, Satyin Kaura
BMC Musculoskeletal Disorders|September 21, 2011
Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort studySarika Ogale, Elena Hitraya, Henry J Henk
Journal of Medical Economics|December 20, 2011
Retrospective evaluation of the clinical benefit of long-term continuous use of zoledronic acid in patients with lung cancer and bone metastasesHenry J Henk, Satyin Kaura, April Teitelbaum
Ophthalmology|January 4, 2003
Atopy: a patient-specific risk factor for diffuse lamellar keratitisStephen M Boorstein, Henry J Henk, Victor M Elner
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 14, 2011
Some cautions on the use of instrumental variables estimators in outcomes research: how bias in instrumental variables estimators is affected by instrument strength, instrument contamination, and sample sizeWilliam H Crown, Henry J Henk, David J Vanness
Mayo Clinic Proceedings|August 20, 2019
Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes: Population-Based Modeling Study, 2011-2014Grace K Mahoney, Henry J Henk, Rozalina G McCoy
Advances in Therapy|November 21, 2015
A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with HyperlipidemiaHenry J Henk, Carly J Paoli, Shravanthi R Gandra
Clinical Therapeutics|December 4, 2014
Real-world analysis of tyrosine kinase inhibitor treatment patterns among patients with chronic myeloid leukemia in the United StatesHenry J Henk, Mabel Woloj, Mark Shapiro, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Novel Type 2 Diabetes Medication Access and Effect of Patient Cost SharingHenry J Henk, Janice M S Lopez, Brahim K Bookhart
Pageof 5